Pathophysiology |
· Small airway swelling + mucus -> obstruction · Destruction of lung parenchyma -> emphysema |
COPD complications |
T1RF: · VQ mismatch · ↓PaO2 · ±Pulmonary hypertension · ±Cor pulmonale T2RF: · Hyperexpansion + gas trapping + dynamic airways compression · Inefficient ventilatory mechanics · ↑PaCO2 Other: · Apical bullae + IPPV -> pneumothorax |
Smoking complications |
Respiratory: · Airway hyperreactivity -> laryngospasm, bronchospasm · Carboxyhaemoglobinaemia -> ↓PaO2 · Impaired mucociliary escalator -> pneumonia Cardiovascular: · IHD · Stroke Immunological: · Wound dehiscence · Wound infection · Pain Haem: · VTE |
GOLD staging |
|
|||||||||
- Spirometry |
1. >80% 2. 50-80% 3. 30-50% 4. <30% |
|||||||||
- Clinical |
|
|||||||||
BODE index |
· BMI · Obstruction (FEV1) · Dyspnoea (mMRC) · Exercise (6MWT) |
Questions |
· Severity? · Optimisation? · Complications? · Airway reactivity? |
Decisions: |
· Proceed vs cancel? · GA vs regional? · HDU vs ward? |
History |
Smoking: · Pack years · If quit, how long ago · Productive cough COPD: · Severity: limitation, home O2 · Exacerbations: frequency, hospitalisation, ICU · Treatment · Current status |
Examination |
· General: barrel chest, WOB, ↑E-time, pursed lips, cyanosis · Vitals: SpO2 · Resp: hyperinflated, decreased expansion, wheeze vs quiet |
Investigations |
· PEFR · Spirometry · TTE |
· Stop smoking
· SABA (salbutamol)
· LAMA (tiotropium, glycopyrronium)
· LABA (salmeterol, indacaterol)
· ICS (fluticasone)
· Surgery
Feedback welcome at ketaminenightmares@gmail.com